72448-31-8

Basic information

• Product Name: [1S-, 2R-, 5R-](3-Aza-bicyclo[3.1.0]hex-2-yl)-methanol
• Synonyms: [1S-, 2R-, 5R-](3-Aza-bicyclo[3.1.0]hex-2-yl)-methanol;(1S,2S,5R)-3-azabicyclo[3.1.0]hexan-2-ylMethanol HCl;3-Azabicyclo[3.1.0]hexane-2-methanol, (1R,2R,5S)-rel-;(1S,2R,5R)-(3-Aza-bicyclo[3.1.0]hex-2-yl)-methanol HCl
• CAS NO: 72448-31-8
• Molecular Formula: C6H11NO
• Molecular Weight: 113.15764
• Mol File: 72448-31-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: [1S-, 2R-, 5R-](3-Aza-bicyclo[3.1.0]hex-2-yl)-methanol(CAS DataBase Reference)
• NIST Chemistry Reference: [1S-, 2R-, 5R-](3-Aza-bicyclo[3.1.0]hex-2-yl)-methanol(72448-31-8)
• EPA Substance Registry System: [1S-, 2R-, 5R-](3-Aza-bicyclo[3.1.0]hex-2-yl)-methanol(72448-31-8)

Safety Data

• Hazardous Substances Data: 72448-31-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
[1S-, 2R-, 5R-](3-Aza-bicyclo[3.1.0]hex-2-yl)-methanol is used as a potential pharmaceutical agent due to its distinctive molecular structure and properties. Its unique stereochemistry and the presence of a hydroxyl group may offer novel therapeutic opportunities, although further research and development are required to fully understand and harness its potential in medicinal applications.
It is important to handle and study [1S-, 2R-, 5R-](3-Aza-bicyclo[3.1.0]hex-2-yl)-methanol with caution and adhere to safety protocols, given its complex nature and potential reactivity. Further exploration of its properties and applications will be crucial in determining its role in the pharmaceutical industry.

Upstream product

• 33294-81-4 (1R,2S,5S)-3-azabicyclo[3.1.0]hexane-2-carboxylic acid 

Downstream Products

• 1092504-95-4 N-methyl-N-({(1R,2S,5S)-3-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-3-azabicyclo[3.1.0]hex-2-yl}methyl)-1,3-benzoxazol-2-amine 
• 1092506-57-4 N-methyl-N-({(1S,2R,5R)-3-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-3-azabicyclo[3.1.0]hex-2-yl}methyl)-1,3-benzoxazol-2-amine 
• 1092504-94-3 N-({(1R,2S,5S)-3-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-3-azabicyclo[3.1.0]hex-2-yl}methyl)-1,3-benzoxazol-2-amine 
• 1092506-56-3 N-({(1S,2R,5R)-3-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-3-azabicyclo[3.1.0]hex-2-yl}methyl)-1,3-benzoxazol-2-amine 
• 1092506-48-3 benzyl (1R,2S,5S)-2-[(1,3-benzoxazol-2-ylamino)methyl]-3-azabicyclo[3.1.0]hexane-3-carboxylate 
• 1092506-49-4 benzyl (1S,2R,5R)-2-[(1,3-benzoxazol-2-ylamino)methyl]-3-azabicyclo[3.1.0]hexane-3-carboxylate 

Relevant articles and documents

Novel series of pyrrolotriazine analogs as highly potent pan-Aurora kinase inhibitors

The synthesis and SAR for a novel series of pyrrolotriazines as pan-Aurora kinase inhibitors are described. Optimization of the cyclopropane carboxamide terminus of lead compound 1 resulted in analogs with high cellular activity and improved rat PK profiles. Notably, compound 17l demonstrated tumor growth inhibition in a mouse xenograft model.

AURORA KINASE COMPOUNDS AND METHODS OF THEIR USE

Provided herein are pyrrolotriazine compounds for treatment of Aurora kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.

CYCLOPROPYL PYRROLIDINE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to cyclopropyl proline bis-amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.